Features

Software report: Deep learning takes to the air

Clinical Practice
Sameer Trikha, Nicolas Jaccard and Jay Lakhani describe a new development offering clinical decision support for the detection of diabetic retinopathy, glaucoma and age related macular degeneration detection through the use of artificial intelligence

The demand for ophthalmic care is soaring. It is estimated that by the year 2020, a total of 415 million people worldwide will be suffering from diabetic eye disease, 76 million will have glaucoma and approximately 196 million will be suffering from age related macular degeneration.1,2 At the same time. the supply of trained ophthalmic care professionals will not be able to keep up with this demand.3

Screening challenges

Conventional medical research studies have identified that early and prompt recognition of abnormalities through eye screening has tangible benefits and improves eye health. As a result, primary eye care providers and optometrists have become the cornerstone for this approach, in many ways acting as ‘gatekeepers’ for NHS Hospital Eye Services.

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.

Register

Already have an account? Sign in here